GO:0006598 polyamine catabolic process: Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006598 (polyamine catabolic process) describes the chemical reactions and pathways that break down polyamines, organic compounds containing two or more amino groups.
• Polyamine catabolism controls intracellular pools of putrescine, spermidine and spermine, which are essential for translation, cell growth and stress responses.
• Key catabolic enzymes include SAT1, SMOX, PAOX, MAOA, MAOB and SSAT, which mediate acetylation, oxidation and back-conversion reactions.
• Dysregulated polyamine catabolism is linked to cancer, neurodegeneration, ferroptosis and lysosomal storage disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect causal roles of polyamine catabolic genes.
• EDITGENE provides end-to-end CRISPR services including KO, point mutation, knock-in, overexpression and library screening for polyamine catabolism research.
Description
Polyamines are small, positively charged organic molecules that contain two or more amino groups and are indispensable for fundamental cellular processes such as DNA stability, RNA binding and protein synthesis. The Gene Ontology term GO:0006598, polyamine catabolic process, refers to the chemical reactions and pathways that result in the breakdown of polyamines, including putrescine, spermidine and spermine. This catabolic process is not merely a disposal route; it is a dynamically regulated hub that adjusts polyamine availability, generates reactive by-products and interfaces with redox biology and iron homeostasis. Researchers study polyamine catabolism because its dysregulation contributes to cancer progression, immune evasion, neurodegeneration and metabolic stress. Understanding the enzymes, intermediates and regulatory loops of GO:0006598 is therefore essential for both basic cell biology and therapeutic development.
polyamine catabolic process At A Glance
| GO ID | GO:0006598 |
|---|---|
| GO term | polyamine catabolic process |
| Ontology | biological_process |
| Synonym | polyamine back-conversion; polyamine breakdown; polyamine catabolism; polyamine degradation; polyamine interconversion |
| Major function | Breakdown and interconversion of putrescine, spermidine and spermine to regulate intracellular polyamine pools |
| Key enzymes | SAT1, SMOX, PAOX, MAOA, MAOB, SSAT |
| Substrates | Putrescine, spermidine, spermine and their acetylated derivatives |
| Cellular location | Cytosol, peroxisome and mitochondria |
| Related processes | Translation regulation, ferroptosis suppression, lysosomal export |
What Is GO:0006598?
According to the QuickGO definition, GO:0006598 (polyamine catabolic process) encompasses the chemical reactions and pathways resulting in the breakdown of polyamines, which are any organic compound containing two or more amino groups. This includes oxidative deamination, acetylation-dependent back-conversion and interconversion reactions that reduce polyamine chain length or convert one polyamine into another. The term is synonymous with polyamine back-conversion, polyamine breakdown, polyamine catabolism, polyamine degradation and polyamine interconversion.
Why Is polyamine catabolic process Important in Cell Biology?
Polyamine catabolic process (GO:0006598) is critically important because it determines the availability of polyamines required for translation, cell proliferation and stress adaptation. Catabolic enzymes such as SAT1 and SMOX produce hydrogen peroxide and aldehydes, which can influence redox signaling and cell fate. In cancer, altered polyamine catabolism supports tumor growth and immunosuppression, making it a therapeutic target. In neurodegeneration, impaired lysosomal polyamine export and catabolism contribute to neuronal dysfunction. Thus, GO:0006598 sits at the intersection of metabolism, gene regulation and disease.
• Regulates intracellular polyamine pools needed for translation and cell growth.
• Generates reactive oxygen species and aldehydes that modulate stress responses.
• Linked to cancer progression, metastasis and immunosuppressive tumor microenvironment.
• Implicated in ferroptosis suppression via polyamine-iron buffering.
• Associated with lysosomal storage disorders and neurodegeneration through ATP13A2 dysfunction.
• Influences intestinal aging via diet-microbiota-polyamine axis.
• Provides metabolic intermediates for back-conversion and interconversion pathways.
• Serves as a target for anticancer and neuroprotective drug development.
• Essential for understanding polyamine homeostasis in pancreatic cancer.
• Enables CRISPR-based functional genomics of metabolic pathways.
What Happens During polyamine catabolic process?
Acetylation and Back-Conversion
In simple terms: Polyamines are first tagged with an acetyl group, which allows them to be converted into other polyamines or broken down.
The catabolic process often begins with acetylation of spermidine or spermine by spermidine/spermine N1-acetyltransferase (SAT1), producing N1-acetylspermidine or N1-acetylspermine. These acetylated intermediates can be oxidized by polyamine oxidase (PAOX) to yield putrescine or spermidine, respectively, in a back-conversion reaction. This step reduces the polyamine chain length and helps maintain homeostasis.
Oxidative Deamination by SMOX
In simple terms: Spermine oxidase directly breaks down spermine, producing hydrogen peroxide and an aldehyde.
Spermine oxidase (SMOX) catalyzes the oxidation of spermine to spermidine, generating hydrogen peroxide and 3-aminopropanal. This reaction is a major source of oxidative stress within cells and can influence apoptosis and ferroptosis. SMOX activity is tightly regulated and contributes to polyamine pool depletion under stress.
Monoamine Oxidase-Mediated Degradation
In simple terms: Monoamine oxidases can also break down polyamines, linking catabolism to neurotransmitter metabolism.
Monoamine oxidase A (MAOA) and MAOB can oxidatively deaminate polyamines, although their primary substrates are neurotransmitters. This cross-reactivity connects polyamine catabolism to redox balance and mitochondrial function. Inhibitors of MAO enzymes can alter polyamine levels, suggesting a regulatory overlap.
Lysosomal Export and Interconversion
In simple terms: Polyamines can be transported out of lysosomes and interconverted between different forms.
ATP13A2 mediates lysosomal polyamine export, and its deficiency disrupts polyamine catabolism and interconversion. This transport step is essential for maintaining cytosolic polyamine pools and for preventing lysosomal dysfunction. Interconversion pathways allow putrescine, spermidine and spermine to be converted into one another, fine-tuning their relative levels.
Integration with Iron and Ferroptosis
In simple terms: Polyamine breakdown products can buffer iron and protect cells from a type of cell death called ferroptosis.
Recent evidence shows that polyamines buffer labile iron to suppress ferroptosis, and catabolic intermediates may modulate this buffering capacity. This links GO:0006598 to iron homeostasis and lipid peroxidation pathways. The interplay between polyamine catabolism and ferroptosis is an emerging area of research.
Key Genes Involved in GO:0006598 polyamine catabolic process
The following genes and proteins are central to the polyamine catabolic process (GO:0006598) and are frequently studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SAT1 | Acetylates spermidine and spermine, initiating back-conversion | Key regulator of polyamine pools; linked to cancer and stress responses |
| SMOX | Oxidizes spermine to spermidine, producing H2O2 | Generates oxidative stress; implicated in cancer and ferroptosis |
| PAOX | Oxidizes acetylated polyamines in back-conversion | Controls putrescine and spermidine levels |
| MAOA | Oxidative deamination of polyamines and neurotransmitters | Connects polyamine catabolism to mitochondrial function |
| MAOB | Oxidative deamination of polyamines and neurotransmitters | Potential target for modulating polyamine levels |
| SSAT | Alternative name for SAT1; acetylates polyamines | Same as SAT1; used in catabolism studies |
| ATP13A2 | Lysosomal polyamine exporter | Deficiency disrupts polyamine catabolism and causes neurodegeneration |
| ODC1 | Ornithine decarboxylase, polyamine biosynthesis | Provides substrate for catabolism; often co-studied |
| AZIN1 | Antizyme inhibitor, regulates ODC | Indirectly affects polyamine catabolism |
| OAZ1 | Antizyme, targets ODC for degradation | Regulates polyamine biosynthesis and catabolism balance |
| SRM | Spermidine synthase | Produces spermidine, substrate for catabolism |
| SMS | Spermine synthase | Produces spermine, substrate for catabolism |
| ARG1 | Arginase, produces ornithine | Links arginine metabolism to polyamine catabolism |
| NOS2 | Nitric oxide synthase, competes for arginine | Affects polyamine substrate availability |
| TP53 | Tumor suppressor, regulates polyamine catabolism | Mutant p53 alters polyamine flux |
| MYC | Oncogene, drives polyamine biosynthesis | Indirectly influences catabolic demand |
| HIF1A | Hypoxia-inducible factor, regulates metabolic genes | May modulate polyamine catabolism under hypoxia |
| NFE2L2 | NRF2, regulates oxidative stress response | Links polyamine catabolism to redox defense |
How Is polyamine catabolic process Regulated?
Polyamine catabolic process (GO:0006598) is regulated at multiple levels. Antizyme (OAZ1) inhibits ornithine decarboxylase and can influence polyamine availability for catabolism. SAT1 expression is induced by polyamine excess, cytokines and stress signals, while SMOX is regulated by inflammatory mediators. mTOR signaling and the integrated stress response (ISR) can modulate translation and metabolic flux, indirectly affecting polyamine catabolism. Additionally, ATP13A2-mediated lysosomal export controls substrate access to catabolic enzymes. These regulatory layers ensure that polyamine levels are maintained within a narrow physiological range.
polyamine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SAT1 | Cancer, oxidative stress | CRISPR KO in cancer cell lines; overexpression models |
| SMOX | Cancer, ferroptosis | Point mutation of catalytic residues; KO in tumor cells |
| ATP13A2 | Kufor-Rakeb syndrome, neurodegeneration | Knock-in of patient mutations in iPSC-derived neurons |
| PAOX | Metabolic disorders | KO in hepatocytes; knock-in of variants |
| MAOA/MAOB | Neurodegeneration, cancer | Double KO in neuronal and cancer cells |
Cancer
Dysregulated polyamine catabolism is a hallmark of many cancers. SAT1 and SMOX are often overexpressed in tumors, leading to altered polyamine pools that support proliferation and survival. In pancreatic cancer, polyamine catabolism contributes to an immunosuppressive tumor microenvironment, suggesting that targeting GO:0006598 could enhance immunotherapy. Small-molecule inhibitors of catabolic enzymes are being explored as anticancer agents.
Neurodegeneration
Mutations in ATP13A2, a lysosomal polyamine exporter, cause Kufor-Rakeb syndrome and disrupt polyamine catabolism, leading to neuronal toxicity. Impaired catabolism may contribute to Parkinson's disease and other neurodegenerative disorders. Modulating polyamine catabolism is a potential neuroprotective strategy.
Ferroptosis and Metabolic Stress
Polyamines buffer labile iron to suppress ferroptosis, and catabolic intermediates can influence this process. Dysregulated polyamine catabolism may sensitize cells to ferroptosis, linking GO:0006598 to iron-dependent cell death. This has implications for cancer therapy and ischemic injury.
Intestinal Aging
The diet-microbiota-polyamine axis influences intestinal aging, with microbial polyamine catabolism affecting host physiology. Altered polyamine catabolism in the gut may contribute to age-related intestinal dysfunction. Probiotics and functional foods targeting this axis are under investigation.
From polyamine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SAT1 loss alter polyamine pools? | CRISPR KO of SAT1 in HeLa or HEK293 cells |
| Does SMOX catalytic activity affect ferroptosis? | Point mutation of SMOX active site; ferroptosis assays |
| Does ATP13A2 mutation impair lysosomal export? | Knock-in of ATP13A2 mutations in iPSC-derived neurons |
| Can polyamine catabolism be visualized in live cells? | Tagged knock-in of SAT1 or SMOX with fluorescent protein |
| Does overexpression of PAOX reduce putrescine? | Overexpression of PAOX in cancer cell lines |
| Which genes regulate polyamine catabolism? | CRISPR library screening with polyamine-sensitive reporters |
How to Study the polyamine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Polyamine and acetyl-polyamine levels | Quantifying catabolic flux in KO cells |
| Ribo-seq | Translation efficiency | Assessing impact of polyamine depletion |
| CRISPR KO screening | Gene essentiality and resistance | Identifying regulators of polyamine catabolism |
| Western blot | Protein expression of SAT1, SMOX, PAOX | Validating CRISPR models |
| Enzyme activity assay | SMOX or PAOX catalytic activity | Measuring point-mutation effects |
| Live-cell imaging | Subcellular localization of tagged enzymes | Studying lysosomal export |
| Ferroptosis assay | Lipid peroxidation and cell death | Linking polyamine catabolism to ferroptosis |
| RNA-seq | Transcriptional changes | Pathway analysis after catabolism perturbation |
Metabolomics and Polyamine Quantification
Mass spectrometry-based metabolomics allows direct measurement of putrescine, spermidine, spermine and their acetylated derivatives, providing a readout of GO:0006598 activity. This method is essential for validating CRISPR models.
Ribo-seq and Translation Profiling
Ribo-seq can reveal how changes in polyamine catabolism affect global translation, as polyamines are required for translation elongation. This is particularly useful in cells with SAT1 or SMOX perturbations.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modify polyamine catabolism and its downstream effects. These screens are powerful for discovering novel regulators of GO:0006598.
Imaging and Reporter Assays
Fluorescent reporters and tagged knock-in cell lines enable live-cell imaging of polyamine catabolism enzymes and their localization. Such models help link enzyme activity to cellular phenotypes.
How CRISPR Can Be Used to Study GO:0006598 polyamine catabolic process
Knockout
CRISPR knockout of SAT1, SMOX, PAOX or ATP13A2 in cell lines abolishes specific catabolic steps, allowing researchers to measure changes in polyamine pools and downstream phenotypes. KO models are ideal for loss-of-function studies of GO:0006598.
Point Mutation
Point mutations in catalytic residues of SMOX or PAOX can dissect enzymatic activity from scaffolding functions. Such models are valuable for understanding the precise chemistry of polyamine catabolism.
Knock-in
Knock-in of disease-associated mutations, such as ATP13A2 variants, in iPSCs or cell lines recapitulates human pathology and enables mechanistic studies of polyamine catabolism in neurodegeneration.
Overexpression
Overexpression of SAT1 or SMOX via CRISPR activation or lentiviral delivery can deplete polyamines and induce oxidative stress, modeling cancer-associated metabolic states.
How EDITGENE Supports polyamine catabolic process Research
Researchers studying polyamine catabolic process-related genes often need to determine whether a candidate gene is causally involved in polyamine breakdown, cellular stress or disease phenotypes. EDITGENE provides validated CRISPR tools and services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for polyamine catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SMOX Knockout HEK293 Cell Line | EDJ-KQ11441 | Human | 54498 | Details Get a Quote |
| PAOX Knockout HEK293 Cell Line | EDJ-KQ11568 | Human | 196743 | Details Get a Quote |
| PAOX Knockout HCT 116 Cell Line | EDJ-KQ38575 | Human | 196743 | Details Get a Quote |
| SMOX Knockout A-549 Cell Line | EDJ-KQ39709 | Human | 54498 | Details Get a Quote |
| SMOX Knockout HCT 116 Cell Line | EDJ-KQ39710 | Human | 54498 | Details Get a Quote |
| SMOX Knockout HeLa Cell Line | EDJ-KQ39711 | Human | 54498 | Details Get a Quote |
| PAOX Knockout HeLa Cell Line | EDJ-KQ58977 | Human | 196743 | Details Get a Quote |
| PAOX Knockout A-549 Cell Line | EDJ-KQ67462 | Human | 196743 | Details Get a Quote |
| SMOX (c.1176A>G )Point Mutation in HAP1 Cell Line | EDC03610 | Human | 54498 | Details Get a Quote |
Displaying Records 1 To 9 Of 9 Records
Frequently Asked Questions About polyamine catabolic process
What is polyamine catabolic process?
Polyamine catabolic process (GO:0006598) is the set of chemical reactions and pathways that break down polyamines, organic compounds with two or more amino groups, including putrescine, spermidine and spermine.
What genes are involved in polyamine catabolic process?
Key genes include SAT1, SMOX, PAOX, MAOA, MAOB and ATP13A2, which mediate acetylation, oxidation and transport steps in polyamine breakdown.
Why is polyamine catabolism important in cancer?
Altered polyamine catabolism supports tumor growth, immune evasion and oxidative stress, making it a therapeutic target in multiple cancers.
How does polyamine catabolism relate to ferroptosis?
Polyamines buffer labile iron to suppress ferroptosis, and catabolic intermediates can modulate this buffering, linking GO:0006598 to iron-dependent cell death.
What is the role of SAT1 in polyamine catabolism?
SAT1 acetylates spermidine and spermine, initiating back-conversion and breakdown, thereby controlling intracellular polyamine pools.
What is the role of SMOX in polyamine catabolism?
SMOX oxidizes spermine to spermidine, producing hydrogen peroxide and contributing to oxidative stress and ferroptosis regulation.
How is polyamine catabolism regulated?
It is regulated by antizyme, SAT1 induction, mTOR signaling, the integrated stress response and lysosomal export via ATP13A2.
What diseases are linked to polyamine catabolic process?
Cancer, neurodegeneration (e.g., Kufor-Rakeb syndrome), ferroptosis-related disorders and intestinal aging have been linked to altered polyamine catabolism.
What methods are used to study polyamine catabolism?
LC-MS metabolomics, Ribo-seq, CRISPR screening, enzyme activity assays and live-cell imaging are commonly used.
How can CRISPR help study polyamine catabolic process?
CRISPR knockout, point mutation, knock-in and overexpression models allow precise dissection of gene function in polyamine catabolism and disease.
Conclusion
GO:0006598 (polyamine catabolic process) is a fundamental biological process that controls polyamine homeostasis, translation, oxidative stress and cell fate. Its dysregulation is implicated in cancer, neurodegeneration, ferroptosis and aging, making it a rich area for therapeutic discovery. CRISPR-based models are indispensable for causally linking catabolic genes to phenotypes and for identifying new drug targets. EDITGENE offers comprehensive CRISPR services to accelerate research on polyamine catabolism and related pathways.
References
- 1. Casero RA Jr et al.. 2018. Polyamine metabolism and cancer: treatments, challenges and opportunities.. Nat Rev Cancer 18(11):681-695 PMID: 30181570
- 2. Schibalski RS et al.. 2024. The role of polyamine metabolism in cellular function and physiology.. Am J Physiol Cell Physiol 327(2):C341-C356 PMID: 38881422
- 3. van Veen S et al.. 2020. ATP13A2 deficiency disrupts lysosomal polyamine export.. Nature 578(7795):419-424 PMID: 31996848
- 4. Sharma P et al.. 2026. Polyamines buffer labile iron to suppress ferroptosis.. Cell 189(18):5571-5589.e10 PMID: 42600612
- 5. Damiani E et al.. 2018. Polyamines and Cancer.. Methods Mol Biol 1694:469-488 PMID: 29080189
- 6. Jiang S et al.. 2025. Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment.. Cancer Lett 633:218016 PMID: 40945572
- 7. Dever TE et al.. 2018. Roles of polyamines in translation.. J Biol Chem 293(48):18719-18729 PMID: 30323064
- 8. Mafe AN et al.. 2026. The Diet-Microbiota-Polyamine Axis in Intestinal Aging: Microbial Pathways, Functional Foods, and Physiological Implications.. Nutrients 18(4) PMID: 41754095
